C07K 2319/50
Containing protease site
Official title: containing protease site
C07K2319/50 (Containing protease site) appears on 1,386 US grants and 2,471 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,386
- Published applications
- 2,471
- Assignees
- 1,095
- Inventors
- 4,992
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 4 | 0 |
| 1987 | 3 | 0 |
| 1988 | 6 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 5 | 0 |
| 1992 | 7 | 0 |
| 1993 | 11 | 0 |
| 1994 | 9 | 0 |
| 1995 | 9 | 0 |
| 1996 | 13 | 0 |
| 1997 | 22 | 0 |
| 1998 | 36 | 0 |
| 1999 | 20 | 0 |
| 2000 | 13 | 0 |
| 2001 | 15 | 3 |
| 2002 | 16 | 19 |
| 2003 | 10 | 42 |
| 2004 | 5 | 30 |
| 2005 | 13 | 37 |
| 2006 | 14 | 35 |
| 2007 | 11 | 24 |
| 2008 | 15 | 39 |
| 2009 | 22 | 41 |
| 2010 | 26 | 52 |
| 2011 | 23 | 53 |
| 2012 | 22 | 51 |
| 2013 | 35 | 67 |
| 2014 | 45 | 76 |
| 2015 | 53 | 94 |
| 2016 | 50 | 106 |
| 2017 | 81 | 87 |
| 2018 | 58 | 115 |
| 2019 | 74 | 135 |
| 2020 | 94 | 154 |
| 2021 | 92 | 163 |
| 2022 | 85 | 219 |
| 2023 | 89 | 199 |
| 2024 | 95 | 260 |
| 2025 | 111 | 209 |
| 2026 | 64 | 161 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Expression of nitrogenase polypeptides in plant cells29 Sep 2026US 12,747,428 B2Commonwealth Scientific and Industrial Research Organisation
- T cell receptors recognizing R273C or Y220C mutations in P531 Sep 2026US 12,721,890 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Multi-transgenic pig for Xenotransplantation25 Aug 2026US 12,714,077 B2Revivicor, Inc.
- TGF-beta RII mutant and fusion protein thereof25 Aug 2026US 12,715,904 B2Mabwell (Shanghai) Bioscience Co., Ltd.
- Regulated synthetic gene activation systems18 Aug 2026US 12,709,637 B2Trustees of Boston University
- Chimeric Cytokine Receptors and Methods of Use8 Oct 2026US 2026/0308235 A1
- Methods and compositions for treating cancer1 Oct 2026US 2026/0297152 A1
- Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides1 Oct 2026US 2026/0297153 A1
- Recombinant expression vector for production of virus-like particle-based multivalent norovirus vaccine and manufacturing method therefor24 Sep 2026US 2026/0284173 A1Inthera Inc.
- Methods of using il-18 fusion proteins17 Sep 2026US 2026/0274968 A1Fuse Biotherapeutics Inc.
Most cited
By later US patents
- Expression using fused genes providing for protein product297US 4,751,180 AChiron Corporation · 1988
- Expression and export technology of proteins as immunofusins276US 5,541,087 AFuji ImmunoPharmaceuticals Corporation · 1996
- Hybridoma and monoclonal antibody for use in an immunoaffinity purification system210US 5,011,912 AImmunex Corporation · 1991
- Novel atrial natriuretic/vasodilator polypeptides181US 4,764,504 ABiotechnology Research Associates, J.V. · 1988
- Albumin fusion proteins157US 6,905,688 B2Human Genome Sciences, Inc. · 2005